CARDIOVASCULAR THERAPEUTICS

被引：0
|
作者：
HAYES, AH [1 ]
机构：
[1] PENN STATE UNIV MILTON S HERSHEY MED CTR,COLL MED,MILTON S HERSHEY MED CTR,HERSHEY,PA 17033
来源：
POSTGRADUATE MEDICINE | 1976年 / 59卷 / 05期
关键词：
D O I：
10.1080/00325481.1976.11714360
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：133 / 133
页数：1
相关论文
共 50 条
  • [41] Novel Inflammatory Biomarkers in Cardiovascular Therapeutics
    Tsigkou, Vicky
    Siasos, Gerasimos
    Oikonomou, Evangelos
    Zaromitidou, Marina
    Latsios, George
    Vavuranakis, Manolis
    Deftereos, Spyridon
    Cleman, Michael W.
    Kokkou, Eleni
    Limberi, Maria
    Dimitropoulos, Stathis
    Zografos, Thodoris
    Marinaki, Smaragdi
    Stefanadis, Christodoulos
    Tousoulis, Dimitris
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (23) : 2773 - 2785
  • [42] Highlights of Transcatheter Cardiovascular Therapeutics 2019
    Giustino, Gennaro
    Leon, Martin B.
    Stone, Gregg W.
    CIRCULATION, 2019, 140 (23) : 1943 - 1945
  • [43] Applications of nanoparticles in cardiovascular imaging and therapeutics
    Oey, Oliver
    Sunjaya, Anthony Paulo
    ASIAN CARDIOVASCULAR & THORACIC ANNALS, 2022, 30 (06): : 653 - 660
  • [44] Future horizons in cardiovascular molecular therapeutics
    Dzau, VJ
    Gibbons, GH
    Mann, M
    BraunDullaeus, R
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (9A): : I33 - I39
  • [45] The Interface of Therapeutics and Genomics in Cardiovascular Medicine
    Magavern, E. F.
    Kaski, J. C.
    Turner, R. M.
    Janmohamed, A.
    Borry, P.
    Pirmohamed, M.
    CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (03) : 663 - 676
  • [46] Oligonucleotide therapeutics - Novel cardiovascular targets
    Isner, JM
    NATURE MEDICINE, 1997, 3 (08) : 834 - 835
  • [47] Aptamers as candidate therapeutics for cardiovascular indications
    Keefe, Anthony D.
    Schaub, Robert G.
    CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (02) : 147 - 152
  • [48] MODULATION OF THE DOPAMINERGIC SYSTEM IN CARDIOVASCULAR THERAPEUTICS
    MURPHY, MB
    BASS, AS
    GOLDBERG, LI
    ENZYMES AS TARGETS FOR DRUG DESIGN, 1989, : 17 - 29
  • [49] More Changing Times at Cardiovascular Therapeutics
    Krum, Henry
    Lang, Chim
    CARDIOVASCULAR THERAPEUTICS, 2010, 28 (03) : 133 - 134
  • [50] Vasodilating β-adrenoceptor blockers as cardiovascular therapeutics
    Toda, N
    PHARMACOLOGY & THERAPEUTICS, 2003, 100 (03) : 215 - 234
12345